APA (7th ed.) Citation

Ziemssen, T., Groth, M., Ettle, B., & Bopp, T. Neutralizing antibody titers over 12 months after SARS-CoV-2 mRNA vaccine booster in patients with relapsing multiple sclerosis continuously treated with ofatumumab. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Ziemssen, Tjalf, Marie Groth, Benjamin Ettle, and Tobias Bopp. Neutralizing Antibody Titers over 12 Months After SARS-CoV-2 MRNA Vaccine Booster in Patients with Relapsing Multiple Sclerosis Continuously Treated with Ofatumumab. Taylor & Francis Group.

MLA (9th ed.) Citation

Ziemssen, Tjalf, et al. Neutralizing Antibody Titers over 12 Months After SARS-CoV-2 MRNA Vaccine Booster in Patients with Relapsing Multiple Sclerosis Continuously Treated with Ofatumumab. Taylor & Francis Group.